Founded in 2021 by Dr.Tseng and a team of PhD researchers from China and abroad, Novelty develops dissolving microneedle and transdermal delivery technologies.
Our work connects formulation science, microneedle design, precision molding, and product development.
In 2023, we received a cosmetics manufacturing license, launched the Shudiya microcrystal line, and began OEM and ODM services. We have since expanded our medical-device R&D and manufacturing infrastructure.
We support brands and industry partners with custom development, contract manufacturing, and joint R&D.
2021Company founded.2023Received a cosmetics manufacturing license. Launched Shudiya microcrystal products and OEM/ODM services.2024Recognized as a National High-tech Enterprise.2025Launched medical-device R&D.2026Completed the medical-device production area and began trial production.Year-end 2026Planned completion of the Yangzhou facility for new dosage forms using dissolving microneedles.PLANNED
PURPOSE & VALUES
Our culture
VISION
Vision
Advance transdermal delivery through an open platform for personalized healthcare.
MISSION
Mission
Our mission is to explore how medicines interact with skin—and develop simple, practical approaches to painless drug delivery.
Innovate
Explore materials, processes and applications.
Collaborate
Create value with development partners.
Act responsibly
Embed quality, safety and responsibility.
Improve
Translate ideas through evidence and disciplined execution.
CREDENTIALS
Credentials
High-tech Enterprise Certificate
Certificate GR202432010407. Issued December 16, 2024; valid for three years.
Cosmetic listing number: 53-356508-877239. Registration documentation issued by Shenzhen KDC Testing Service Co., Ltd.; not an FDA-issued certificate or product approval.
Cosmetic listing number: 53-369619-317413. Registration documentation issued by Shenzhen KDC Testing Service Co., Ltd.; not an FDA-issued certificate or product approval.
